Heilmittel Group, through its member companies BHW Bayerische Heilmittel Wissenschaften GmbH (Germany) and NAH – North American Heilmittel Inc. (Canada), is pleased to announce the upcoming expansion of the CollaMouv® product line with three new targeted formulations: CollaMouv® Athlete, CollaMouv® Kids, and CollaMouv® Schön.
Each of these new variants is Made in Germany under GMP-certified conditions, reflecting the group’s continued commitment to delivering scientifically formulated collagen-based solutions tailored to specific age groups and health needs.
The expanded CollaMouv® lineup is scheduled for launch in Autumn 2025, with availability planned across select markets in Europe, North America, and the Middle East. These new variants will be made available through the official CollaMouv Shop – www.collamouv.com – and Amazon platforms shortly thereafter.
CollaMouv® Athlete – Performance and Recovery
A powerful sugar-free 25 ml formula developed for athletes and active individuals. It combines 8 g of Kolligreich® Hydrolyzed Collagen, 1 g L-Citrulline, and 2 g Whey Protein Hydrolysate, enhanced with Magnesium, Zinc, Vitamin C, B6, and B12. Designed to support muscle recovery, joint integrity, and endurance performance.
CollaMouv® Kids – Joint and Growth Support for Children
A child-friendly 10 ml orange-flavored shot with no added sugar, featuring 2 g of Kolligreich®Collagen along with essential nutrients such as Vitamin D3, Vitamin C, and B-Complex. Specially formulated to support healthy growth, joint development, and bone structure in children.
CollaMouv® Schön – Beauty and Mobility for Women
Targeted at women aged 25 and above, this 25 ml drinkable shot blends 5 g of Kolligreich®Collagen (Types I & II) with Hyaluronic Acid, Biotin, Vitamin C, and Zinc. It is designed to promote radiant skin, hair, and nails while enhancing joint flexibility and comfort.
This expansion marks a strategic milestone for the CollaMouv® brand, positioning it as a comprehensive family of functionally differentiated collagen solutions. All variants are supported by scientific research and are currently undergoing multilingual packaging and regulatory preparation for the EU, Canada, and MENA regions.
For distribution, retail, and pharmacy inquiries, please visit www.collamouv.com to explore partnership opportunities.